
A structure-first approach to blepharoplasty and filler yields more durable, natural results.
AI accelerates retina trials and imaging insights, boosts screening access, and raises urgent questions on regulation, privacy, and equity.
Artificial intelligence is reshaping how retina specialists design clinical trials, screen patients, and interpret imaging, according to a collection of ophthalmologists and vision researchers who discussed the technology's expanding role—and its limitations—in eye care.

